IFCI Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 10:36 pm

Quick Insight

IFCI Ltd, a term lending institution in the finance industry, currently trades at a price of ₹51.6 with a market capitalization of ₹13,889 Cr. Despite a relatively high P/E ratio of 43.3, the company exhibits a low ROE of 2.60% and ROCE of 8.08%. Operating profit margin stands at a healthy 47%, with a net profit of ₹349 Cr. The company's reserves amount to ₹5,996 Cr, while borrowings total ₹3,714 Cr, resulting in a comfortable interest coverage ratio of 2.45x. With a price-to-book value of 2.45x and a CCC of 41 days, IFCI Ltd's performance suggests a need for improved profitability efficiency to enhance shareholder value and investor confidence.

Competitors of IFCI Ltd

All Competitor Stocks of IFCI Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:25 am

Below is a detailed analysis of the quarterly data for IFCI Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 407.00 Cr.. The value appears to be declining and may need further review. It has decreased from 414.00 Cr. (Mar 2025) to 407.00 Cr., marking a decrease of 7.00 Cr..
• For Expenses, as of Jun 2025, the value is 215.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -80.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 295.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 193.00 Cr.. The value appears to be declining and may need further review. It has decreased from 493.00 Cr. (Mar 2025) to 193.00 Cr., marking a decrease of 300.00 Cr..
• For OPM %, as of Jun 2025, the value is 47.00%. The value appears to be declining and may need further review. It has decreased from 119.00% (Mar 2025) to 47.00%, marking a decrease of 72.00%.
• For Other Income, as of Jun 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 36.00 Cr., marking an increase of 35.00 Cr..
• For Interest, as of Jun 2025, the value is 104.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 134.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 30.00 Cr..
• For Depreciation, as of Jun 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 103.00 Cr.. The value appears to be declining and may need further review. It has decreased from 340.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 237.00 Cr..
• For Tax %, as of Jun 2025, the value is 39.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 39.00%, marking an increase of 16.00%.
• For Net Profit, as of Jun 2025, the value is 62.00 Cr.. The value appears to be declining and may need further review. It has decreased from 260.00 Cr. (Mar 2025) to 62.00 Cr., marking a decrease of 198.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.15. The value appears to be declining and may need further review. It has decreased from 0.84 (Mar 2025) to 0.15, marking a decrease of 0.69.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:15 pm

Growth

Last Updated: September 5, 2025, 6:50 am

Balance Sheet

Last Updated: June 16, 2025, 11:59 am

Below is a detailed analysis of the balance sheet data for IFCI Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 2,694.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,490.00 Cr. (Mar 2024) to 2,694.00 Cr., marking an increase of 204.00 Cr..
• For Reserves, as of Mar 2025, the value is 5,996.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,045.00 Cr. (Mar 2024) to 5,996.00 Cr., marking an increase of 3,951.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3,714.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5,367.00 Cr. (Mar 2024) to 3,714.00 Cr., marking a decrease of 1,653.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 13,319.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,016.00 Cr. (Mar 2024) to 13,319.00 Cr., marking an increase of 4,303.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 25,724.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18,918.00 Cr. (Mar 2024) to 25,724.00 Cr., marking an increase of 6,806.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,700.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,734.00 Cr. (Mar 2024) to 1,700.00 Cr., marking a decrease of 34.00 Cr..
• For CWIP, as of Mar 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2024) to 22.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 15,323.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,678.00 Cr. (Mar 2024) to 15,323.00 Cr., marking an increase of 6,645.00 Cr..
• For Other Assets, as of Mar 2025, the value is 8,678.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,493.00 Cr. (Mar 2024) to 8,678.00 Cr., marking an increase of 185.00 Cr..
• For Total Assets, as of Mar 2025, the value is 25,724.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,918.00 Cr. (Mar 2024) to 25,724.00 Cr., marking an increase of 6,806.00 Cr..

Notably, the Reserves (5,996.00 Cr.) exceed the Borrowings (3,714.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for IFCI Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 5. It has increased from -0.95 (Mar 23) to 0.42, marking an increase of 1.37.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 5. It has increased from -0.95 (Mar 23) to 0.42, marking an increase of 1.37.
• For Cash EPS (Rs.), as of Mar 24, the value is 1.29. This value is below the healthy minimum of 3. It has increased from -0.20 (Mar 23) to 1.29, marking an increase of 1.49.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 28.84. It has increased from 28.55 (Mar 23) to 28.84, marking an increase of 0.29.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 28.84. It has increased from 28.55 (Mar 23) to 28.84, marking an increase of 0.29.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 7.98. It has increased from 6.76 (Mar 23) to 7.98, marking an increase of 1.22.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 5.62. This value is within the healthy range. It has increased from 3.38 (Mar 23) to 5.62, marking an increase of 2.24.
• For PBIT / Share (Rs.), as of Mar 24, the value is 5.30. This value is within the healthy range. It has increased from 3.05 (Mar 23) to 5.30, marking an increase of 2.25.
• For PBT / Share (Rs.), as of Mar 24, the value is 3.02. This value is within the healthy range. It has increased from 0.11 (Mar 23) to 3.02, marking an increase of 2.91.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.96. This value is below the healthy minimum of 2. It has increased from -0.54 (Mar 23) to 0.96, marking an increase of 1.50.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 0.41. This value is below the healthy minimum of 2. It has increased from -0.94 (Mar 23) to 0.41, marking an increase of 1.35.
• For PBDIT Margin (%), as of Mar 24, the value is 70.46. This value is within the healthy range. It has increased from 50.02 (Mar 23) to 70.46, marking an increase of 20.44.
• For PBIT Margin (%), as of Mar 24, the value is 66.39. This value exceeds the healthy maximum of 20. It has increased from 45.04 (Mar 23) to 66.39, marking an increase of 21.35.
• For PBT Margin (%), as of Mar 24, the value is 37.79. This value is within the healthy range. It has increased from 1.75 (Mar 23) to 37.79, marking an increase of 36.04.
• For Net Profit Margin (%), as of Mar 24, the value is 12.13. This value exceeds the healthy maximum of 10. It has increased from -8.06 (Mar 23) to 12.13, marking an increase of 20.19.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.21. This value is below the healthy minimum of 8. It has increased from -13.98 (Mar 23) to 5.21, marking an increase of 19.19.
• For Return on Networth / Equity (%), as of Mar 24, the value is 2.56. This value is below the healthy minimum of 15. It has increased from -6.17 (Mar 23) to 2.56, marking an increase of 8.73.
• For Return on Capital Employeed (%), as of Mar 24, the value is 16.41. This value is within the healthy range. It has increased from 9.71 (Mar 23) to 16.41, marking an increase of 6.70.
• For Return On Assets (%), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 5. It has increased from -1.22 (Mar 23) to 0.54, marking an increase of 1.76.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.33. This value exceeds the healthy maximum of 1. It has decreased from 1.79 (Mar 23) to 1.33, marking a decrease of 0.46.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.11. It has increased from 0.09 (Mar 23) to 0.11, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 24, the value is 1.55. This value is within the healthy range. It has increased from 1.45 (Mar 23) to 1.55, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 24, the value is 1.55. This value is within the healthy range. It has increased from 1.44 (Mar 23) to 1.55, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.04. This value is below the healthy minimum of 4. It has decreased from 0.05 (Mar 23) to 0.04, marking a decrease of 0.01.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 2.45. This value is below the healthy minimum of 3. It has increased from 1.16 (Mar 23) to 2.45, marking an increase of 1.29.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.42. This value is below the healthy minimum of 3. It has increased from 0.81 (Mar 23) to 1.42, marking an increase of 0.61.
• For Enterprise Value (Cr.), as of Mar 24, the value is 13,349.42. It has increased from 7,323.61 (Mar 23) to 13,349.42, marking an increase of 6,025.81.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.72. This value exceeds the healthy maximum of 3. It has increased from 4.93 (Mar 23) to 6.72, marking an increase of 1.79.
• For EV / EBITDA (X), as of Mar 24, the value is 9.54. This value is within the healthy range. It has decreased from 9.86 (Mar 23) to 9.54, marking a decrease of 0.32.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.98. This value exceeds the healthy maximum of 3. It has increased from 1.45 (Mar 23) to 4.98, marking an increase of 3.53.
• For Price / BV (X), as of Mar 24, the value is 2.45. This value is within the healthy range. It has increased from 0.64 (Mar 23) to 2.45, marking an increase of 1.81.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.98. This value exceeds the healthy maximum of 3. It has increased from 1.45 (Mar 23) to 4.98, marking an increase of 3.53.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.09 (Mar 23) to 0.01, marking an increase of 0.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness